益生菌VSL#3对DSS大鼠结肠炎TLR4-NF-κB通路的调节作用 |
| |
引用本文: | 张孟爽,牛敏 刘淑敏 杜娜 尧静 陈辞言 杜艳. 益生菌VSL#3对DSS大鼠结肠炎TLR4-NF-κB通路的调节作用[J]. 中国抗生素杂志, 2019, 44(5): 643-S1 |
| |
作者姓名: | 张孟爽 牛敏 刘淑敏 杜娜 尧静 陈辞言 杜艳 |
| |
摘 要: | 目的 阐明益生菌VSL#3对硫酸葡聚糖钠(DSS)诱导结肠炎大鼠TLR4-NF-κB通路的影响,深入探讨VSL#3对结肠黏膜炎症免疫调控机制。方法 将33只Sprague-Dawly大鼠(SD大鼠)分为正常组、DSS造模组以及益生菌治疗组。5% DSS溶液自由饮用一周,构建溃疡性结肠炎模型。观察和评价大肠黏膜的组织学损伤,计算DAI评分以及病理学评分;使用real-time PCR检测结肠组织TLR4、NF-κB、TNF-α、IL-1β mRNA的表达水平;Western-Blot检测TLR4、NF-κB蛋白的表达水平;应用酶联免疫吸附测定(ELISA)检测血清中TNF-α和IL-1β的表达。结果 益生菌治疗组DAI评分、病理学评分均低于DSS造模组(P<0.05);益生菌治疗组大鼠结肠组织中TLR4、NF-κB、TNF-α、IL-1β的mRNA水平与DSS造模组相比表达下调,差异具有统计学意义(P<0.05);与DSS造模组相比,益生菌治疗组SD大鼠结肠组织TLR4、NF-κB p65蛋白水平下调,血清TNF-α、IL-1β表达水平降低,差异具有统计学意义(P<0.05)。结论 益生菌VSL#3可能是通过抑制TLR4-NF-κB通路,发挥其抑制免疫,减轻炎症反应的作用,从而达到治疗溃疡性结肠炎的目的。
|
关 键 词: | 硫酸葡聚糖钠 溃疡性结肠炎 VSL#3 TLR4 NF-&kappa B |
The regulating effects of probiotics VSL#3 on the TLR4-NF-κB pathway in rats with DSS-induced colitis |
| |
Abstract: | Objective To elucidate the effects of probiotic VSL#3 on the TLR4-NF-κB pathway in rats with DSS-induced colitis, and to further investigate the immunoregulatory mechanism of VSL#3 on colon mucosa inflammation. Methods 33 Sprague-Dawly rats (SD rats) were randomly divided into three groups. Those rats were given access to 5% dextran sulfate sodium (DSS) solution ad libitum for a week to build the model of experimental acute enteritis. Observe and evaluate the histological damage of colorectal mucosa, calculate the DAI score and pathological score. Real-time PCR was used to detect the mRNA levels of TLR4, NF-κB, IL-1β, and TNF-α in the rat colon mucosa. Western-Blot was used to detect the protein levels of TLR4 and NF-κB in colon mucosa. Serum IL-1β and TNF-α in rats were detected by ELISA. Results DAI scores and pathology scores in probiotics groups were lower than those in the model group (P<0.05). The mRNA levels of TLR4, NF-κB, TNF-α, and IL-1β in the colonic tissue of the probiotic treatment group were down regulated compared with those of the DSS mod model, and thedifferences were statistically significant (P<0.05). Compared with the DSS model group, the levels of TLR4 and NF-κB p65 protein in the colon of the SD rats treated with probiotics were decreased, and the levels of serum TNF-α and IL-1β were decreased, the differences were statistically significant (P<0.05). Conclusion VSL#3 may achieve the goal of treating ulcerative colitis by inhibiting the TLR4-NF-κB pathway so as to inhibit immune and suppress inflammatory |
| |
Keywords: | DSS Ulcerative colitis VSL#3 TLR4 NF-κB |
|
| 点击此处可从《中国抗生素杂志》浏览原始摘要信息 |
|
点击此处可从《中国抗生素杂志》下载全文 |
|